Oracle Introduces Oracle(r) Health Sciences Central Coding 3.0
Oracle today announced the availability of Oracle® Health Sciences Central Coding Release 3.0. The third generation of the Web-based clinical trial data coding and dictionary management application includes expanded query management and automated workflows that help clinical trial sponsors and contract research organizations (CROs) improve the efficiency and consistency of the coding process.
Oracle Health Sciences Central Coding Release 3.0 features enhanced integration with Oracle Health Sciences InForm Global Trial Management Global Trial Management system, which promotes greater productivity via improved query management and workflow. This release enables users to create and manage Oracle Health Sciences InForm Global Trial Management queries directly in Oracle Health Sciences Central Coding Release 3.0, streamlining the coding process with one point of entry to apply and manage coding updates to all Oracle Health Sciences InForm Global Trial Management-managed trials in process.
It features:
- A flexible, multilingual application that automates coding and minimizes the manual effort required to code verbatim terms, Oracle Health Sciences Central Coding Release 3.0 is the first coding solution to be certified by the Uppsala Monitoring Center, the World Health Organization collaborative center for international drug monitoring.
- A new user interface and simplified status information. Customizable flags and status options enable users to tailor and optimize their workflow.
- Auto-query, propagate, and auto-close tools enhance productivity by reducing the manual effort required to raise and resolve queries.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
